Kapvay Medication Information
KapvayTM (clonidine ER) is available only by prescription and is used to treat attention deficit hyperactivity disorder (ADHD). It is not a stimulant or a controlled substance, and it is the first ADHD medication that can be used in combination with stimulants.
Kapvay is approved for use in children and adolescents age 6 to 17 years old. It is not appropriate for everyone. To help ensure a safe treatment process, be sure your child's healthcare provider has up-to-date information on your child's medical history and current medications.
This medicine comes in the form of an extended-release tablet and is taken once or twice a day. Side effects may include drowsiness, fatigue, and irritability. In most cases, reactions to this drug are minor and easy to treat.
(Click Kapvay for more information on this medication. This article discusses the effectiveness of this drug, overdose information, and safety precautions to be aware of before beginning treatment.)